# DESCRIPTION

## BACKGROUND OF THE DISCLOSURE

## BRIEF SUMMARY OF THE DISCLOSURE

## DETAILED DESCRIPTION OF THE DISCLOSURE

### I. Definitions

### II. Target Polypeptide Description

### III. Anti-SEMA4D Antibodies

### IV. MeCP2

### V. Characteristic Symptoms of Rett Syndrome

### VI. Astrocytes

### VII. Treatment Methods Using Therapeutic Anti-SEMA4D Antibodies

### VIII. Pharmaceutical Compositions and Administration Methods

## EXAMPLES

### Example 1: Testing the Effects of an Anti-SEMA4D Binding Molecule on Symptoms Associated with Rett Syndrome in the Mecp2T158A Rett Syndrome Mouse Model

